Imagion Biosystems Limited
IBXXF
$0.01
-$0.025-71.43%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.75% | -35.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.75% | -35.94% | |||
| Cost of Revenue | -2.63% | -79.22% | |||
| Gross Profit | -2.76% | -24.89% | |||
| SG&A Expenses | -2.76% | -56.96% | |||
| Depreciation & Amortization | -3.85% | -97.95% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.76% | -66.00% | |||
| Operating Income | -2.73% | 119.28% | |||
| Income Before Tax | 2.76% | 64.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.76% | 64.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.76% | 64.02% | |||
| EBIT | -2.73% | 119.28% | |||
| EBITDA | -39.38% | 160.26% | |||
| EPS Basic | 3.13% | 79.22% | |||
| Normalized Basic EPS | 5.00% | 79.17% | |||
| EPS Diluted | 3.13% | 79.22% | |||
| Normalized Diluted EPS | 5.00% | 79.17% | |||
| Average Basic Shares Outstanding | 0.00% | 75.55% | |||
| Average Diluted Shares Outstanding | 0.00% | 75.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
